VacV-001

N/A

Report date: 2025/01/26 17:00:04

Base Information

Drug NameVacV-001
Drug Alias NameOncolytic vaccinia virus based therapy (VacV Biotherapeutics)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Pancreatic Ductal +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVacV Biotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVacV Biotherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Pancreatic Ductal +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A